Pain affects more lives than the total number of lives affected by heart disease, cancer, and diabetes combined (Institute of Medicine Report, 2011). Pain is a leading cause of disability and a major public health problem. Moreover, the issue of ensuring appropriate interdisciplinary assessment and treatment of pain has a far-reaching impact on morbidity, mortality, quality of life, and economics—both of individuals and across the healthcare system. There is a continued need to connect the work of researchers studying the science of pain with those from multiple disciplines who seek to use the best-available evidence to treat and thus improve pain care. As the United States’ premier pain meeting, the American Pain Society (APS) provides attendees with a unique forum for sharing advances and standards in evidence based pain research and treatment by colleagues from all disciplines in pain, in a setting that encourages interactions between scientists and clinicians.
This meeting accomplishes that by providing you the opportunity to:
The APS 32nd Annual Scientific Meeting is intended for physicians, nurses, basic scientists, pharmacists, psychologists, and other healthcare professionals who make up the interdisciplinary pain community. Generalists and specialists will benefit from a wide range of topics and faculty presenting basic, translational, and clinical research and treatment advancements.
The APS 32nd Annual Scientific Meeting will offer current information about the diagnosis, treatment, and management of acute pain, chronic cancer and noncancer pain, and recurrent pain. Presentations are designed to enhance research or clinical skills pertinent to pain management and will feature content appropriate for professionals at several experience levels. The meeting is an arena for interdisciplinary exchange among pain scientists and healthcare professionals. By participating in this meeting, attendees can expect to achieve the following objectives:
There are no prerequisites for participation in this activity.
Physicians Continuing Education
Psychologist Continuing Education
Pharmacists Continuing Education
Disclosure
It is the policy of APS that the planners, faculty, and this provider disclose the existence of any significant financial interest or other relationships they and/or their spouse/partner may have with the manufacturers of any commercial products or services relating to the topics presented in the educational activity. APS also requires disclosure of the intent to discuss unlabeled uses of a commercial product or investigational use of a product not yet approved for this purpose. It is the responsibility of the Scientific Program Committee to review potential conflicts of interest as submitted in the disclosure form and resolve such conflicts. Resolving the conflict ensures that the content of the activity is aligned with the interests of the public. Detailed disclosure information will be published in course materials. Learners will also be informed when no relevant financial relationships exist.
Disclaimer
The material presented in this activity represents the opinion of the speakers and not necessarily the views of APS.
Statement of Non-Endorsement
Accredited status does not imply endorsement by APS or the ACCME, ACPE, ANCC, or APA of any commercial products displayed in conjunction with this activity.